TY - JOUR
T1 - Dual effects of hepatitis C virus Core protein on the transcription of cyclin-dependent kinase inhibitor p21 gene
AU - Kwun, H. J.
AU - Jang, Kyung Lib
PY - 2003/7/1
Y1 - 2003/7/1
N2 - Transcription of p21 was activated in hepatitis C virus (HCV) Core-expressing HepG2 cells where its upstream p53 was stabilized. However, this effect was not absolutely required for the activation of p21 by Core, as demonstrated in Hep3B cells. In addition, an opposite effect on the transcription of p21 was observed in NIH3T3 and primary hepatocytes, where p53 was not decreased by Core. To explain the p53-independent regulation of p21 by Core, we identified a Core-responsive element between positions -74 and -83 of the p21 promoter, exactly overlapped with a tumour growth factor β (TGF-β)/butyrate responsive element. Furthermore, we demonstrated that Core could activate the p21 through the element by stimulating a butyrate pathway, whereas this was inhibited through a TGF-β pathway. The opposing effects of Core protein on the transcription of p21 might be important in understanding the progression of hepatic disease in HCV-positive patients.
AB - Transcription of p21 was activated in hepatitis C virus (HCV) Core-expressing HepG2 cells where its upstream p53 was stabilized. However, this effect was not absolutely required for the activation of p21 by Core, as demonstrated in Hep3B cells. In addition, an opposite effect on the transcription of p21 was observed in NIH3T3 and primary hepatocytes, where p53 was not decreased by Core. To explain the p53-independent regulation of p21 by Core, we identified a Core-responsive element between positions -74 and -83 of the p21 promoter, exactly overlapped with a tumour growth factor β (TGF-β)/butyrate responsive element. Furthermore, we demonstrated that Core could activate the p21 through the element by stimulating a butyrate pathway, whereas this was inhibited through a TGF-β pathway. The opposing effects of Core protein on the transcription of p21 might be important in understanding the progression of hepatic disease in HCV-positive patients.
UR - http://www.scopus.com/inward/record.url?scp=0037707408&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0037707408&partnerID=8YFLogxK
U2 - 10.1046/j.1365-2893.2003.00434.x
DO - 10.1046/j.1365-2893.2003.00434.x
M3 - Article
C2 - 12823590
AN - SCOPUS:0037707408
SN - 1352-0504
VL - 10
SP - 249
EP - 255
JO - Journal of Viral Hepatitis
JF - Journal of Viral Hepatitis
IS - 4
ER -